Late-Stage Research

 
News Articles for Late-Stage Research top ^
2014/12/9
By Michael Calia Eli Lilly and Co.
Sign-up for Eli Lilly, Incyte arthritis drug meets endpoint in late-stage trial investment picks
2015/1/12
-- New trial of niraparib for the treatment of ovarian cancer to begin in Q1 2015 -- HRD assay to be incorporated into Phase 3 NOVA trial of niraparib in ovarian cancer -- Initial Phase 3 data from NOVA is expected to become available in 2015 --
Sign-up for CORRECTING and REPLACING -- TESARO Announces Expansion of Niraparib Clinical Program and Outlines Late-Stage Program Milestones for 2015 investment picks
2015/1/12
-- New trial of niraparib for the treatment of ovarian cancer to begin in Q1 2015 -- HRD assay to be incorporated into Phase 3 NOVA trial of niraparib in ovarian cancer -- Initial Phase 3 data from NOVA is expected to become available in 2015 --
Sign-up for TESARO Announces Expansion of Niraparib Clinical Program and Outlines Late-Stage Program Milestones for 2015 investment picks
2015/1/29
GUELPH, Ontario, Canada , Jan.
Sign-up for Canadian Solar Provides an Update on its Late-Stage Solar Project Pipeline investment picks
2015/2/27
Biogen Idec (BIIB) and Sweden's Swedish Orphan Biovitrum (SE:SOBI) , or Sobi, said on Friday a Phase 3 trial of its hemophilia treatment in children under 12 met its primary endpoint.
Sign-up for Biogen, Sobi late-stage trial for hemophilia treatment meets endpoint investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Late-Stage Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Late Trading  |  Next: Latest Research